Arun Sridhar
About
My primary research focus is investigating the effects of IBD-drug targets on intestinal epithelial cells (IECs) with particular emphasis on elucidating the mode of action of various JAK/TYK2 inhibitors and their impact on the epithelium.
Publications
2025
-
Sridhar, Arun;
Bakke, Ingunn;
Gopalakrishnan, Shreya;
Osoble, Nimo Mukhtar Mohamud;
Hammarqvist, Emilie Prytz;
Pettersen, Henrik Sahlin.
(2025)
Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids.
Scientific Reports
Academic article
Journal publications
-
Sridhar, Arun;
Bakke, Ingunn;
Gopalakrishnan, Shreya;
Osoble, Nimo Mukhtar Mohamud;
Hammarqvist, Emilie Prytz;
Pettersen, Henrik Sahlin.
(2025)
Tofacitinib and budesonide treatment affect stemness and chemokine release in IBD patient-derived colonoids.
Scientific Reports
Academic article
Outreach
2025
-
Popular scientific lectureSridhar, Arun; Walaas, Gunnar Andreas; Sæterstad, Siri; Hansen, Marianne Dore; Østvik, Ann Elisabeth; Bakke, Ingunn. (2025) Investigating the effects of JAK-inhibitors on inflammatory responses in intestinal epithelial cells using IBD patient-derived colonoids . 60th NBS Contact Meeting 2025-02-23 - 2026-01-26
2024
-
Popular scientific lectureSridhar, Arun. (2024) How Does Different Classes of IBD Drugs Affect Intestinal Epithelial Homeostasis and Function? . Best practice nordic MEDtalk , https://bpno.no/medtalks/how-does-different-classes-of-ibd-d 2024-11-06 - 2024-11-06
-
PosterSridhar, Arun; Bakke, Ingunn; Østvik, Ann Elisabeth; Pettersen, Henrik Sahlin; Bruland, Torunn. (2024) The impact of tofacitinib and budesonide on stemness, cell death, and chemokine release in IBD patient-derived colonoids . UEG Week 2024-10-12 - 2024-10-15